Use of Chemotherapy and Other Cancer-Directed Therapies in the ICU for Patients with Cancer.

Authors

Dharani K Narendra, Cristina Gutierrez

Published in

Journal of intensive care medicine. Pages 8850666261486819. Sep 28, 2026. Epub Sep 28, 2026.

Abstract

The global burden of cancer is rising, and patients with malignancy who are critically ill account for 15%-20% of intensive care unit (ICU) admissions. A common indication for ICU admission is the presence of oncological emergencies that require organ support or close monitoring, while patients receive cancer therapy. The administration of chemotherapy in the ICU for selective patients with malignancy is feasible and is associated with considerable long-term survival and disease-free survival. Newer therapies such as targeted therapies and immunotherapies have significantly improved prognosis in malignancies that were considered terminal, and their use continues to increase exponentially. While indications surrounding chemotherapy treatment in the ICU are well documented, the role of these newer therapies in the setting of oncologic emergencies and critical illness is not well reported. This review summarizes the available evidence regarding the timing and indications for administration of chemotherapy and newer cancer regimens in the ICU for hematological and solid malignancies, its associated complications, emerging therapeutic options, and overall prognosis.

PMID:
42804185
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.